Skip to main content

Table 4 Prognostic factors in the univariate analyses for overall survival

From: Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer

Variables Median OS (months) p
Age   
   60 years and over 11 ± 2 0.87
   Less than 60 years 12 ± 3  
Gender   
   Male 9 ± 3 0.22
   Female 15 ± 6  
PS   
   0 15 ± 3 0.015*
   1–2 6 ± 2  
Histology   
   Adenocarcinoma 15 ± 5 0.73
   Squamous cell 13 ± 7  
   NSCLC 11 ± 3  
Stage at presentation   
   III NR 0.018*
   IV 9 ± 2  
Smoking history   
   Yes 9 ± 2 0.20
   No NR  
Response after 3 cycles of CT   
   PR 13 ± 2 0.047*
   Other 6 ± 1  
  1. * Statistically significant
  2. † Mean OS is 15 ± 2 months
  3. PS: ECOG Performance status; NR: Not reached; CT: Chemotherapy